These agonists contribute to increased insulin secretion in response to hyperglycemia, suppression of glucagon secretion under hyper- or euglycemic conditions, delayed gastric emptying to prevent substantial post-meal glycemic spikes, and a decrease in calorie intake and body weight [83]. The gene discussed is INS; the disease is Hyperglycemia.